עד 24%: התרופה המוכרת שנקשרה לסיכון נמוך יותר לאלצהיימר

הערכה

A large observational study of over 120,000 adults links common osteoporosis drugs to a 24% lower dementia risk. The finding adds weight to the idea of a bone-brain axis, where skeletal health influences cognition. But this is association, not causation. The researchers themselves stress that clinical trials are needed before anyone repositions these drugs as Alzheimer's preventives. Watch for whether that trial evidence materializes, and how the medical community weighs the risk-benefit for patients already on these medications.